首页 | 本学科首页   官方微博 | 高级检索  
     

2200例门静脉高压症患者行脾切除贲门周围血管离断术的近期疗效观察
引用本文:余灵祥张绍庚郭晓东肖朝辉赵德希孙佳轶张培瑞李志伟.2200例门静脉高压症患者行脾切除贲门周围血管离断术的近期疗效观察[J].现代生物医学进展,2014,14(10):1883-1885.
作者姓名:余灵祥张绍庚郭晓东肖朝辉赵德希孙佳轶张培瑞李志伟
作者单位:解放军第302医院,北京100039
基金项目:北京市科技计划首都临床特色应用研究专项(z131100004013041)
摘    要:目的:总结脾切除贲门周围血管离断术治疗门静脉高压症的近期疗效。方法:回顾性分析我院1999年6月-2013年6月收治的2200例择期行脾切除贲门周围血管离断术的肝硬化门静脉高压症患者的临床资料。统计并分析手术前后的止血率、并发症及肝功能指标等。结果:近期随访率78%(1716/2200);其中,上消化道出血史88.3%(1515例),手术止血率为99.1%(1701例),围术期病死率为1.3%(22例),主要死亡原因为感染和肝肾功能衰竭;并发症情况:发热39.8%(683例)、腹腔内出血2%(34例)、门静脉系统血栓51%(875例)、胸腹腔感染3.7%(63例)、肝脓肿0.7%(12例)、胃瘘0.3%(5例)及胰瘘0.3%(5例)。丙肝肝硬化脾切除抗病毒103例,预防手术112例,丙肝切脾抗病毒、预防手术围手术期无死亡;肝功能Child分级:术前85%为A级,术后94%为A级;ALB、TBil、PT及腹水消失率均明显好转。结论:脾切除贲门周围血管离断术对门静脉高压症引起的上消化道出血具有积极的作用,可获得较好的近期疗效,并发症经对症处理可消除或缓解,但如何有效降低术后门静脉系统血栓的形成仍需在今后的临床实践中深入研究。

关 键 词:门静脉高压症  脾切除术  贲门周围血管离断术  近期疗效

Short-termEffects of Splenectomy and Esophagogastric Devascularization on the Treatment of Portal Hypertension with 2200 Case*
YU Ling-xiang,ZHANG Shao-geng,GUO Xiao-dong,XIAO Chao-hui,ZHAO De-xi,SUN Jia-yi,ZHANG Pei-rui,LI Zhi-wei.Short-termEffects of Splenectomy and Esophagogastric Devascularization on the Treatment of Portal Hypertension with 2200 Case*[J].Progress in Modern Biomedicine,2014,14(10):1883-1885.
Authors:YU Ling-xiang  ZHANG Shao-geng  GUO Xiao-dong  XIAO Chao-hui  ZHAO De-xi  SUN Jia-yi  ZHANG Pei-rui  LI Zhi-wei
Affiliation:(302 Hospital of PLA, Beijing, 100039, China)
Abstract:Objective: To summarize the short-term effects of the splenectomy combined with the esophagogastfic devascularizat- ion on the treatment of portal hypertension. Methods: A retrospective analysis was performed about the clinical data of 2200 patients who were treated by the splenectomy and esophagogastric devascularization in our hospital from June 1999 to June 2013. Then the clinical data, such as the rate of recent bleeding before and after the treatment, the incidence of complications and the liver function of patients, were collected and analyzed. Results: The rate of follow-ups was 78%(1716); 88.3%(1515) of the patients have the history of upper gastrointestinal bleeding, 99.1%(1701) were taken the surgical hemostasis; The peri-operative mortality was 1.3%(22) of which the main reasons were the infection, the dysfunction of liver and kidney; 39.8%(683) were in fever, 2% (34) represented the intm-abdominal hemorrhage, 51%(875) showed the portal vein thrombosis, 3.7%(63) got the abdominal cavity infection, 0.7% (12) were liver abscess, 0.3%(5) were gastric fistula and 0.3%(5) were pancreatic fistula. There were 103 cases with the hepatitis C cirrhosis undergoing the splenectomy antiviral, 112 cases were taken the preventive surgery with no one death; 85% patients were sorted to A by the Child classification of liver function before the surgery, while the percentage went to 94% when completing the treatment; The indexes of ALB, TBil, PT and the ascites have significantly improved. Conclusion: It is suggested that the short-term effect of the splenectomy combined with the pericardial blood vessel disarticulation on the prevention of upper gastrointestinal bleeding caused by portal hypertension with the advantages of better short-term curative effect and the postoperative complications could be eliminated or reduced by the symptomatical treatment. However, it is more easily lead to the thrombosis of patients with portal hypertension which might be required to explore rnore operative methods.
Keywords:Portal hypertension  Esophagogastric devascularization  Splenectomy  Short-term effect
本文献已被 CNKI 维普 等数据库收录!
点击此处可从《现代生物医学进展》浏览原始摘要信息
点击此处可从《现代生物医学进展》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号